Tower Research Capital (TRC)’s Sonnet BioTherapeutics SONN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82K | Sell |
1,465
-1,122
| -43% | -$1.39K | ﹤0.01% | 4740 |
|
|
2025
Q1 | $3.47K | Sell |
2,587
-3,513
| -58% | -$4.71K | ﹤0.01% | 4405 |
|
|
2024
Q4 | $8.91K | Buy |
6,100
+5,722
| +1,514% | +$8.35K | ﹤0.01% | 3955 |
|
|
2024
Q3 | $2.53K | Sell |
378
-518
| -58% | -$3.47K | ﹤0.01% | 4981 |
|
|
2024
Q2 | $6.73K | Buy |
896
+556
| +164% | +$4.17K | ﹤0.01% | 4549 |
|
|
2024
Q1 | $5.07K | Buy |
340
+78
| +30% | +$1.16K | ﹤0.01% | 4589 |
|
|
2023
Q4 | $3.64K | Buy |
+262
| New | +$3.64K | ﹤0.01% | 5054 |
|
|
2023
Q3 | – | Sell |
-64
| Closed | -$5.53K | – | 6183 |
|
|
2023
Q2 | $5.53K | Buy |
64
+34
| +113% | +$2.94K | ﹤0.01% | 4796 |
|
|
2023
Q1 | $2K | Sell |
30
-23
| -43% | -$1.53K | ﹤0.01% | 5396 |
|
|
2022
Q4 | $11K | Buy |
53
+29
| +121% | +$6.02K | ﹤0.01% | 3867 |
|
|
2022
Q3 | $6K | Buy |
24
+20
| +500% | +$5K | ﹤0.01% | 5050 |
|
|
2022
Q2 | $3K | Buy |
4
+2
| +100% | +$1.5K | ﹤0.01% | 5403 |
|
|
2022
Q1 | $2K | Buy |
2
+1
| +100% | +$1K | ﹤0.01% | 5597 |
|
|
2021
Q4 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 5886 |
|
|
2021
Q2 | – | Hold |
0
| – | -$1K | – | 5818 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 5213 |
|
|
2020
Q4 | – | Sell |
-1
| Closed | -$7K | – | 5390 |
|
|
2020
Q3 | $7K | Sell |
1
-1
| -50% | -$7K | ﹤0.01% | 4250 |
|
|
2020
Q2 | $16K | Buy |
+2
| New | +$16K | ﹤0.01% | 3793 |
|
|
2015
Q1 | – | Hold |
0
| – | -$1K | – | 4899 |
|
|
2014
Q4 | – | Hold |
0
| – | -$1K | – | 3715 |
|
|
2014
Q3 | – | Hold |
0
| – | -$2K | – | 4148 |
|
|
2014
Q2 | – | Hold |
0
| – | -$2K | – | 3456 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 3903 |
|
|
2013
Q3 | – | Hold |
0
| – | -$18K | – | 4824 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 1824 |
|